EODData

MEMBERSHIP REGISTER LOG IN

FRA, 9VC: ATAI LIFE SCIENCES BV EO1

18 Nov 2025
LAST:

3.300

CHANGE:
 0.24		OPEN:
3.342		HIGH:
3.342		ASK:
0.000		VOLUME:
30
CHG(%):
6.78		PREV:
3.540		LOW:
3.300		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
18 Nov 253.3423.3423.3003.30030
17 Nov 253.4323.5403.3473.5405.0K
14 Nov 253.5113.5513.3803.551460
13 Nov 253.7133.8703.7133.8241.5K
12 Nov 253.8043.9463.7203.720526
11 Nov 253.7233.8403.7233.832910
10 Nov 254.0584.2113.9823.98223.4K
07 Nov 253.7803.8313.7003.7002.4K
06 Nov 253.9743.9743.6013.6010
05 Nov 254.5464.5463.9733.973100

PROFILE

Name:ATAI LIFE SCIENCES BV EO1
About:Atai Life Sciences N.V., a clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of mental health treatments in the United States, Germany, and Canada. The company develops BPL-003, an intranasal formulation of the benzoate salt form of mebufotenin that is in Phase 2a and 2b clinical studies for treatment resistant depression (TRD) and alcohol use disorder; RL-007, an orally bioavailable compound, which is a pro-cognitive neuromodulator in Phase 2b trial for cognitive impairment associated with schizophrenia; and ELE-101, a serotonergic psychedelic in Phase 2a trial for the treatment of major depressive disorder. It is also developing VLS-01, an oral transmucosal film formulation of N,N-Dimethyltryptamine in Phase 2 clinical study to treat TRD; EMP-01, an oral formulation of R-3,4-methylenedioxy-methamphetamine that is in Phase 2 clinical study for social anxiety disorder; and EGX-A & EGX-B, which are non-hallucinogenic 5-HT2A receptor agonists in preclinical studies for TRD. In addition, the company offers COMP360 for psilocybin therapy; and GRX-917 for the treatment of anxiety, depression, and various neurological disorders. ATAI Life Sciences N.V. was founded in 2018 and is headquartered in Berlin, Germany.
Sector:Healthcare
Industry:Biotechnology
Address:Wallstraße 16, Berlin, Germany, 10179
Website:https://atai.com
ISIN:NL0015000DX5

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-4.91 
Forward P/E:-4.71 
PEG Ratio:0.08 
Price to Sales:528.83 
Price to Book:6.75 
Operating Margin:-35.15 
Return on Assets:-0.30 
Return on Equity:-0.77 
Revenue:2.0M 
Shares:214.34M 
Market Cap:707.32M 

TECHNICAL INDICATORS

MA5:3.598.7%
MA10:3.7012.2%
MA20:4.3832.6%
MA50:4.4735.4%
MA100:3.8416.4%
MA200:2.7221.4%
RSI14:20.85 
WPR14:-100.00 
MTM14:-1.75
ROC14:-0.35 
ATR:0.31 
Week High:3.9519.6%
Week Low:3.300.0%
Month High:5.9881.2%
Month Low:3.3021.4%
Year High:5.9881.2%
Year Low:1.03220.4%
Volatility:8.96